Erowid
 
 
Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Titles containing 'amphetamine toxicity' OR with Authors including 'amphetamine toxicity' OR with Abstract including 'amphetamine toxicity' OR with Keywords including 'amphetamine toxicity'


Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
Smith DE The Psychotomimetic Amphetamines with Special Reference to DOM (STP) T... Journal of Psychedel... 1969
Bhattacharya, S.K., Sanya... Investigation on the Hallucinogenic Activity of Indole Alkylamines Iso... Indian Journal of Ph... 1971
Consroe PF Specific pharmacological management of acute toxicity due to psychedel... Arizona Medicine. 1972
Nichols DE, Ilhan M, Long... Comparison of Cardiovascular, Hyperthermic, and Toxic Effects of Para-... Arch Int de Pharmaco... 1975
Lopatka JE, Brewerton CN,... The protective effects of methysergide, 6-hydroxydopamine and other ag... Res Commun Chem Path... 1976
Poffenbarger M, Fuller GM Effects of Psychotropic Drugs on Neurotubule Assembly J.Neurochem. 1977
Da Prada M, Pieri L, Kell... Effects of 5,6-Dihydroxytryptamine and 5,7-Dihydroxytryptamine on the ... Ann.N.Y.Acad.Sci. 1978
Davis WM, Bedford JA, Bue... Acute toxicity and gross behavioral effects of amphetamine, four metho... Toxicol Appl Pharmac... 1978
Ricaurte G, Bryan G, Stra... Hallucinogenic amphetamine selectively destroys brain serotonin nerve ... Science 1985
Wesson DR Propylhexedrine Drug Alcohol Depend 1986
Davis WM, Hatoum HT, Wate... Toxicity of MDA (3,4-methylenedioxyamphetamine) considered for relevan... Alcohol Drug Res 1987
Frith CH, Chang LW, Latti... Toxicity of methylenedioxymethamphetamine (MDMA) in the dog and the ra... Fundam Appl Toxicol 1987
Noggle FT Jr, DeRuiter J,... Synthesis, identification, and acute toxicity of some N-alkyl derivati... J Assoc Off Anal Che... 1987
Schmidt CJ Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphet... J Pharmacol Exp Ther 1987
Smilkstein MJ, Smolinske ... A case of MAO inhibitor/MDMA interaction: agony after ecstasy J Toxicol Clin Toxic... 1987
Stone DM, Hanson GR, Gibb... Differences in the central serotonergic effects of methylenedioxymetha... Neuropharmacology 1987
Battaglia G, Yeh SY, de S... MDMA-induced neurotoxicity: parameters of degeneration and recovery of... Pharmacol Biochem Be... 1988
Logan BJ, Laverty R, Sand... Differences between rats and mice in MDMA (methylenedioxymethylampheta... Eur J Pharmacol 1988
O'Hearn E, Battaglia G, D... Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDM... J Neurosci 1988
Scallet AC, Lipe GW, Ali ... Neuropathological evaluation by combined immunohistochemistry and dege... Neurotoxicology 1988
Slikker W Jr, Ali SF, Sca... Neurochemical and neurohistological alterations in the rat and monkey ... Toxicol Appl Pharmac... 1988
Stone DM, Johnson M, Hans... Role of endogenous dopamine in the central serotonergic deficits induc... J Pharmacol Exp Ther 1988
Hekmatpanah CR, McKenna D... Reserpine does not prevent 3,4-methylenedioxymethamphetamine-induced n... Neurosci Lett 1989
Johnson M, Stone DM, Bush... Glucocorticoids and 3,4-methylenedioxymethamphetamine (MDMA)-induced n... Eur J Pharmacol 1989
Kleven MS, Woolverton WL,... Evidence that both intragastric and subcutaneous administration of met... Brain Res 1989
Laverty R, Logan BJ Ecstasy abuse N Z Med J 1989
Lim HK, Foltz RL Identification of metabolites of 3,4-(methylenedioxy)methamphetamine i... Chem Res Toxicol 1989
Peroutka SJ 'Ecstasy': a human neurotoxin? Arch Gen Psychiatry 1989
Seiden LS, Kleven MS Methamphetamine and related drugs: toxicity and resulting behavioral c... NIDA Res Monogr 1989
Stone DM, Hanson GR, Gibb... In vitro reactivation of rat cortical tryptophan hydroxylase following... J Neurochem 1989
Stone DM, Johnson M, Hans... Acute inactivation of tryptophan hydroxylase by amphetamine analogs in... Eur J Pharmacol 1989
Gibb JW, Stone DM, Johnso... Role of dopamine in the neurotoxicity induced by amphetamines and rela... NIDA Res Monogr 1989
Kleven MS, Seiden LS Toxicity of Amphetamine-related Drugs and Resulting Behavioural Change... NIDA Res Monogr 1989
Azmitia EC, Murphy RB, Wh... MDMA (ecstasy) effects on cultured serotonergic neurons: evidence for ... Brain Res 1990
De Souza EB, Battaglia G,... Neurotoxic effect of MDMA on brain serotonin neurons: evidence from ne... Ann N Y Acad Sci 1990
Finnegan KT, Skratt JJ, I... The N-methyl-D-aspartate (NMDA) receptor antagonist, dextrorphan, prev... Neurosci Lett 1990
Gaylor DW, Slikker W Jr Risk assessment for neurotoxic effects Neurotoxicology 1990
Gibb JW, Johnson M, Hanso... Neurochemical basis of neurotoxicity Neurotoxicology 1990
Gibb JW, Johnson M, Stone... MDMA: historical perspectives Ann N Y Acad Sci 1990
Grob C, Bravo G, Walsh R Second thoughts on 3,4-methylenedioxymethamphetamine (MDMA) neurotoxic... Arch Gen Psychiatry 1990
Johnson MP, Huang XM, Obe... Behavioral, biochemical and neurotoxicological actions of the alpha-et... Eur J Pharmacol 1990
McKenna DJ, Peroutka SJ Neurochemistry and neurotoxicity of 3,4-methylenedioxymethamphetamine ... J Neurochem 1990
Nichols DE, Brewster WK, ... Nonneurotoxic tetralin and indan analogues of 3,4-(methylenedioxy)amph... J Med Chem 1990
Nichols DE, Oberlender R Structure-activity relationships of MDMA and related compounds: a new ... Ann N Y Acad Sci 1990
Oberlender R, Nichols DE (+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative... J Pharmacol Exp Ther 1990
Scheffel U, Ricaurte GA Paroxetine as an in vivo indicator of 3,4-methylenedioxymethamphetamin... Brain Res 1990
Schmidt CJ, Abbate GM, Bl... Selective 5-hydroxytryptamine2 receptor antagonists protect against th... J Pharmacol Exp Ther 1990
Schmidt CJ, Black CK, Abb... Chloral hydrate anesthesia antagonizes the neurotoxicity of 3,4-methyl... Eur J Pharmacol 1990
Schmidt CJ, Black CK, Abb... Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity a... Brain Res 1990
Schmidt CJ, Black CK, Tay... Antagonism of the neurotoxicity due to a single administration of meth... Eur J Pharmacol 1990
Chiang CN, Hawks RL Research Findings on Smoking of Abused Substances NIDA Research Monogr... 1990
McKenna DJ, Guan XM, Shul... 3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential eff... Pharmacol Biochem Be... 1991
Paris JM, Cunningham KA Lack of Neurotoxicity after Intra-Raphe Micro-Injections of MDMA ('Ecs... NIDA Res Monogr 1991
Johnson MP, Frescas SP, O... Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphen... J Med Chem 1991
Champney TH, Matthews RT Pineal serotonin is resistant to depletion by serotonergic neurotoxins... J Pineal Res 1991
Huang XM, Johnson MP, Nic... Reduction in brain serotonin markers by alpha-ethyltryptamine (Monase) Eur J Pharmacol 1991
Johnson MP, Frescas SP, O... Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphen... J Med Chem 1991
Johnson MP, Huang XM, Nic... Serotonin neurotoxicity in rats after combined treatment with a dopami... Pharmacol Biochem Be... 1991
Nash JF, Nichols DE Microdialysis studies on 3,4-methylenedioxyamphetamine and structurall... Eur J Pharmacol 1991
Nichols DE, Johnson MP, O... 5-Iodo-2-aminoindan, a nonneurotoxic analogue of p-iodoamphetamine Pharmacol Biochem Be... 1991
Schmidt CJ, Taylor VL, Ab... 5-HT2 antagonists stereoselectively prevent the neurotoxicity of 3,4-m... J Pharmacol Exp Ther 1991
Steele TD, Brewster WK, J... Assessment of the role of alpha-methylepinine in the neurotoxicity of ... Pharmacol Biochem Be... 1991
Henry JA, Jeffreys KJ, Da... Toxicity and deaths from 3,4-methylenedioxymethamphetamine ('ecstasy') Lancet 1992
Grob CS, Bravo GL, Walsh ... The MDMA-neurotoxicity controversy: implications for clinical research... J Nerv Ment Dis 1992
Hashimoto K, Maeda H, Gor... Effects of benzylpiperazine derivatives on the neurotoxicity of 3,4-me... Brain Res 1992
Hashimoto K, Maeda H, Gor... Antagonism of 3,4-methylenedioxymethamphetamine-induced neurotoxicity ... Eur J Pharmacol 1992
Henry JA Ecstasy and the dance of death BMJ 1992
Huang X, Marona-Lewicka D... p-Methylthioamphetamine is a Potent New Non-Neurotoxic Serotonin-Relea... Eur J Pharmacol 1992
Johnson M, Elayan I, Hans... Effects of 3,4-dihydroxymethamphetamine and 2,4,5-trihydroxymethamphet... J Pharmacol Exp Ther 1992
Kosten TR, Price LH Phenomenology and sequelae of 3,4-methylenedioxymethamphetamine use [C... Journal of Nervous &... 1992
Nash JF, Yamamoto BK Methamphetamine neurotoxicity and striatal glutamate release: comparis... Brain Res 1992
Paris JM, Cunningham KA Lack of serotonin neurotoxicity after intraraphe microinjection of (+)... Brain Res Bull 1992
Ricaurte GA, McCann UD Neurotoxic amphetamine analogues: effects in monkeys and implications ... Ann N Y Acad Sci 1992
Steele TD, Katz JL, Ricau... Evaluation of the neurotoxicity of N-methyl-1-(4-methoxyphenyl)-2-amin... Brain Res 1992
Huang X, Marona-Lewicka D... p-methylthioamphetamine is a potent new non-neurotoxic serotonin-relea... Eur J Pharmacol 1992
Ali SF, Newport GD, Scall... Oral administration of 3,4-methylenedioxymethamphetamine (MDMA) produc... Neurotoxicol Teratol 1993
Allen RP, McCann UD, Rica... Persistent effects of (+/- )3,4-methylenedioxymethamphetamine (MDMA, '... Sleep 1993
Barrett PJ 'Ecstasy' misuse--overdose or normal dose? Anaesthesia 1993
Brodkin J, Malyala A, Nas... Effect of acute monoamine depletion on 3,4-methylenedioxymethamphetami... Pharmacol Biochem Be... 1993
Colado MI, Murray TK, Gre... 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MD... Br J Pharmacol 1993
McCann UD, Ricaurte GA Reinforcing subjective effects of (+/-) 3,4-methylenedioxymethamphetam... J Clin Psychopharmac... 1993
Miller DB, O'Callaghan JP The interactions of MK-801 with the amphetamine analogues D-methamphet... Ann N Y Acad Sci 1993
Ricaurte GA, Markowska AL... 3,4-Methylenedioxymethamphetamine, serotonin and memory [published err... J Pharmacol Exp Ther 1993
Robinson TE, Castaneda E,... Effects of cortical serotonin depletion induced by 3,4-methylenedioxym... Neuropsychopharmacol... 1993
Emerson TS, Cisek JE Methcathinone: a Russian designer amphetamine infiltrates the rural mi... Ann Emerg Med 1993
McDowell DM, Kleber HD MDMA: Its history and pharmacology Psychiatric Annals 1994
Axt KJ, Mamounas LA, Moll... Structural Features of Amphetamine Neurotoxicity in the Brain. Ampheta... Academic Press San D... 1994
Bronson ME, Jiang W, Clar... Effects of Designer Drugs on the Chicken Embryo and 1-Day-Old Chicken Brain Res Bull 1994
Gudelsky GA, Yamamoto BK,... Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine rel... Eur J Pharmacol 1994
Marsh JCW, Abboudi ZH, Gi... Aplastic anaemia following exposure to 3,4-methylenedioxymethamphetami... Br J Haematol 1994
McCann UD, Ridenour A, Sh... Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (... Neuropsychopharmacol... 1994
Miller DB, O'Callaghan JP Environment-, drug- and stress-induced alterations in body temperature... J Pharmacol Exp Ther 1994
O'Callaghan JP, Miller DB Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mou... J Pharmacol Exp Ther 1994
Sprague JE, Huang X, Kant... Attenuation of 3,4-methylenedioxymethamphetamine (MDMA) induced neurot... Life Sci 1994
Steele TD, McCann UD, Ric... 3,4-Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): pharmacology and ... Addiction 1994
Tucker GT, Lennard MS, El... The demethylenation of methylenedioxymethamphetamine ('ecstasy') by de... Biochem Pharmacol 1994
House RV, Thomas PT, Bhar... Selective modulation of immune function resulting from in vitro exposu... Toxicology 1995
McCann UD, Ricaurte GA On the neurotoxicity of MDMA and related amphetamine derivatives [lett... J Clin Psychopharmac... 1995
Priori A, Bertolasi L, Be... Acute dystonic reaction to ecstasy Movement Disorders 1995
Miller RT, Serrine SL, Mo... Metabolism of 5-(Glutathion-S-yl)-a-methyldopamine Following Intracere... Chem Res Toxicol 1995

Page 1 of 4   /   371 Entries Returned
Pages:     
 1 
2 3 4 next